Severe hypophosphatemia secondary to chronic treatment with endovenous ferric carboxymaltose Virginia González Hidalgo; Jesús Manuel Morán López;

Real-world evaluation of the efficacy and safety of switching from weekly dulaglutide to weekly semaglutide: The SEMA-SWITCH study Felipe Pardo Lozano; Arantxa Rubio Marcos; Rosa Casañ Fernández; Amparo Bartual Rodrigo; Sergio Martínez-Hervás; Francisco Javier Ampudia-Blasco;

Effect of glucagon-like peptide-1 receptor agonists on the risk of major adverse limb events in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials Fernando Garagoli; Walter Masson; Leandro Barbagelata; Martín Lobo;